Man Group
PRAX icon

Man Group’s Praxis Precision Medicines PRAX Stock Holding History

Man Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.09M Buy
21,164
+17,991
+567% +$5.7M 0.01% 953
2026
Q1 		$1.02M Sell
3,173
-17,997
-85% -$5.57M ﹤0.01% 1827
2025
Q4 		$6.24M Buy
+21,170
New +$3.94M 0.01% 999
2025
Q1 		– Sell
-2,832
Closed -$218K – 2321
2024
Q4 		$218K Sell
2,832
-1,209
-30% -$87.5K ﹤0.01% 1854
2024
Q3 		$233K Sell
4,041
-2,617
-39% -$141K ﹤0.01% 1826
2024
Q2 		$275K Sell
6,658
-9,263
-58% -$438K ﹤0.01% 1807
2024
Q1 		$971K Buy
15,921
+2,782
+21% +$125K ﹤0.01% 1550
2023
Q4 		$293K Buy
+13,139
New +$237K ﹤0.01% 1825
2023
Q1 		– Sell
-20,444
Closed -$863K – 2035
2022
Q4 		$730K Buy
20,444
+4,480
+28% +$140K ﹤0.01% 1409
2022
Q3 		$544K Buy
+15,964
New +$795K ﹤0.01% 1490
2022
Q2 		– Sell
-1,353
Closed -$207K – 2340
2022
Q1 		$207K Buy
+1,353
New +$278K ﹤0.01% 1930

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Man Group's PRAX Position: Q2 2026 in Review

Man Group increased its Praxis Precision Medicines (PRAX) stake by 567% in Q2 2026, buying an estimated $5.7M and bringing the position to 21,164 shares worth $7.09M. The position accounts for 0.01% of the portfolio, ranked #953.

Man Group first reported a position in PRAX in Q1 2022 and has held it in 11 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Man Group held 21,164 shares of Praxis Precision Medicines worth $7.09M as of Q2 2026.
  • Man Group bought 17,991 Praxis Precision Medicines shares in Q2 2026, an estimated $5.7M.
  • Praxis Precision Medicines made up 0.01% of Man Group's portfolio in Q2 2026, its #953 holding.
  • Man Group first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 11 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.